Dally; Robert Dean

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dally; Robert Dean.The latest application filed is for "cd73 inhibitors".

Company Profile

1.9.15

Dally; Robert Dean - Carmel IN
Dally; Robert Dean - Indianapolis IN
Dally; Robert Dean - Zionsville IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CD73 inhibitors Grant 11,028,074 - Dally , et al. June 8, 2	2021-06-08
Cd73 Inhibitors App 20210002257 - DALLY; Robert Dean ; et al.	2021-01-07
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamid- e compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers Grant 9,776,992 - Brooks , et al. October 3, 2	2017-10-03
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamid- E Compounds, Formulations Containing Those Compounds, And Their Use As Aicarft Inhibitors In The Treatment Of Cancers App 20170233378 - BROOKS; Harold Burns ; et al.	2017-08-17
CDC7 inhibitors Grant 9,156,824 - Dally , et al. October 13, 2	2015-10-13
CDC7 Inhibitors App 20140275121 - DALLY; Robert Dean ; et al.	2014-09-18
Selective estrogen receptor modulators for the treatment of vasomotor symptoms Grant 8,217,032 - Dally , et al. July 10, 2	2012-07-10
AKT and P70 S6 kinase inhibitors Grant 8,148,387 - Shepherd , et al. April 3, 2	2012-04-03
P70 S6 Kinase Inhibitors App 20120071490 - Dally; Robert Dean ; et al.	2012-03-22
Selective Estrogen Receptor Modulators For The Treatment Of Vasomotor Symptoms App 20110281847 - Dally; Robert Dean ; et al.	2011-11-17
Kinase inhibitors Grant 7,863,310 - Bonjouklian , et al. January 4, 2	2011-01-04
3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors Grant 7,745,438 - Broughton , et al. June 29, 2	2010-06-29
Akt And P70 S6 Kinase Inhibitors App 20100120801 - Shepherd; Timothy Alan ; et al.	2010-05-13
Selective estrogen receptor modulators containing a phenylsulfonyl group Grant 7,585,977 - Dally , et al. September 8, 2	2009-09-08
P70 S6 Kinase Inhibitors App 20090163714 - Dally; Robert Dean ; et al.	2009-06-25
Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms App 20090023917 - Dally; Robert Dean ; et al.	2009-01-22
Kinase Inhibitors App 20080227839 - Bonjouklian; Rosanne ; et al.	2008-09-18
Selective Estrogen Receptor Modulators Containing A Phenylsulfonyl Group App 20080214612 - Dally; Robert Dean ; et al.	2008-09-04
Benzimidazoles and benzothiazoles as inhibitors of map kinase Grant 7,320,995 - Bonjouklian , et al. January 22, 2	2008-01-22
3-(2-Acylamino-1-Hydroxyethyl)-Morpholine Derivatives and Their Use as Bace Inhibitors App 20070225267 - Broughton; Howard Barff ; et al.	2007-09-27
Pyrrolidine Derivatives Useful As Base Inhibitors App 20070213331 - Dally; Robert Dean ; et al.	2007-09-13
Selective estrogen receptor modulators App 20070111988 - Dally; Robert Dean ; et al.	2007-05-17
Selective estrogen receptor modulators containing a phenylsulfonyl group App 20060183736 - Dally; Robert Dean ; et al.	2006-08-17
Benzimidazoles and benzothiazoles as inhibitors of map kinase App 20050272791 - Bonjouklian, Rosanne ; et al.	2005-12-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.